• Malaysia
  • 25 December 2012
  • Opinion
  • By Mr Rizatuddin Ramli

Mr Rizatuddin Ramli, Bio-XCell: Malaysian biotech sector will ride on private firms in 2013

Updated on 25 December 2012

Bioscience industry trends 2013: Mr Ramli, CEO, Bio-XCell, Malaysia, predicts that the industry in Malaysia will be propelled by collaborations between home-grown companies and foreign enterprises and also by the launch of the Bio-XCell park

mr-rizatuddin-ramli-ceo-bio-xcell-malaysia

Mr Rizatuddin Ramli, CEO, Bio-XCell, Malaysia

With the recent roll-out of the Bioeconomy Initiative Malaysia (BIM 2012), policies are enhanced to ensure continuity and cohesive implementation of all the related national "knowledge-based" policies.

In 2013, we should see more evidence of the private sector acting as a main driver for the biotech industry in Malaysia. There will be an increase in the formation of smart partnerships to utilize and fully maximise the abundant opportunities and resources available. We will also see more home-grown biotech companies and foreign enterprises partnering to catalyse new development and discoveries in the industry.

Nusajaya where Bio-XCell is located will emerge as a hotspot for all the knowledge-driven economies, including biotechnology. The Bio-XCell park will be open for business in 2013 and will significantly contribute to the development of a southern biotech hub together with the institutes of higher learning and partnerships from across the causeway. I hope to see some major global biotech collaborations coming into the Bio-XCell area, taking to its strategic location, integrated lifestyle offerings and facilities for accelerated growth.

Leave a Reply

Post Comment

Special Features

Survey Box

Ranbaxy Controversy

Will the Ranbaxy controversy end the Indian pharma dominion in the US market?

Send this article by email

X